Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recurrent pregnancy loss: an update.

W H Kutteh1

  • 1Department of Obstetrics and Gynecology, The University of Tennessee, Memphis 38163-2116, USA. wkutteh@utmem.1.utmem.edu

Current Opinion in Obstetrics & Gynecology
|October 20, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recurrent pregnancy loss evaluation combined with 24-chromosome microarray of miscarriage tissue provides a probable or definite cause of pregnancy loss in over 90% of patients.

Human reproduction (Oxford, England)·2018
Same author

'Non-criteria' aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, TX, USA, April 2010.

Lupus·2011
Same author

Antiphospholipid antibodies (APA) and recurrent pregnancy loss: treating a unique APA positive population.

Human reproduction (Oxford, England)·2002
Same author

Autoimmune factors in assisted reproduction.

Minerva ginecologica·2002
Same author

Induction of specific immune responses in the genital tract of women after oral or rectal immunization and rectal boosting with Salmonella typhi Ty 21a vaccine.

Journal of reproductive immunology·2001
Same author

Immunological testing and treatment in reproduction: frequency assessment of practice patterns at assisted reproduction clinics in the USA and Australia.

Human reproduction (Oxford, England)·2001
Same journal

Management of hypertensive disorders in pregnancy.

Current opinion in obstetrics & gynecology·2026
Same journal

Updates in group prenatal care research.

Current opinion in obstetrics & gynecology·2026
Same journal

Complex benign gynecology in perimenopause: current evidence and future directions.

Current opinion in obstetrics & gynecology·2026
Same journal

Role of insulin in female reproduction.

Current opinion in obstetrics & gynecology·2026
Same journal

Urinary tract involvement in endometriosis: current evidence and clinical insights into navigating diagnosis and management.

Current opinion in obstetrics & gynecology·2026
Same journal

Updates in ultrasound imaging of adenomyosis and clinical impacts.

Current opinion in obstetrics & gynecology·2026
See all related articles

Recurrent pregnancy loss causes are diverse, including genetic, immune, and environmental factors. Research is exploring autoimmune and alloimmune links, with intravenous immunoglobulin showing promise for immune-related cases.

Area of Science:

  • Reproductive Medicine
  • Immunology
  • Genetics

Background:

  • Recurrent pregnancy loss (RPL) affects a significant number of women.
  • Causes are multifactorial, encompassing genetic, endocrinologic, anatomic, immunologic, microbiologic, and environmental factors.
  • Recent research increasingly focuses on immunologic contributions to RPL.

Purpose of the Study:

  • To review recent studies on the causes and treatments of recurrent pregnancy loss.
  • To highlight emerging research in autoimmune and alloimmune etiologies.
  • To summarize proposed evaluation and treatment strategies.

Main Methods:

  • Literature review of recent studies on recurrent pregnancy loss.
  • Analysis of research investigating genetic, endocrinologic, anatomic, immunologic, microbiologic, and environmental factors.

Related Experiment Videos

  • Examination of studies on autoimmune (antithyroid, antiphospholipid antibodies) and alloimmune (natural killer cells, cytotoxic T cells) factors.

    • Main Results:

    • Autoimmune and alloimmune factors are major areas of recent investigation, though controversies in testing and treatment persist.
    • Intravenous immunoglobulin is emerging as a potential treatment for immunologic causes of RPL.
    • Associations between hypercoagulable states, endocrinologic aberrations (hyperprolactinemia, hyperandrogenism), and social/environmental factors with RPL are being explored.

    Conclusions:

    • Recurrent pregnancy loss has diverse causes requiring comprehensive evaluation.
    • Immunologic factors, particularly autoimmune and alloimmune, are critical areas of ongoing research.
    • Further investigation into novel treatments like intravenous immunoglobulin is warranted.